Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer

STRASBOURG, France & MONTREAL & BOSTON -- Domain Therapeutics a global clinical-stage biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the appointment of Sean A. MacDonald as its Chief Executive Officer (CEO). Read More

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
PIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Exchange Traded Series
Bond yield volatility has fund managers overhauling trading strategies

IPG, a Leader in Packaging Innovation, Launches Second Virtual Showroom, Redefining Customer Engagement With New Immersive Experience
PlantX Announces Proposed Share Consolidation